Dehydrozingerone based 1-acetyl-5-aryl-4,5-dihydro-1H-pyrazoles: Synthesis, characterization and anticancer activity

[1]  T. Kanjevac,et al.  Cytotoxicity of gold(III) complexes on A549 human lung carcinoma epithelial cell line. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

[2]  A. Garg,et al.  Effect of ring A and ring B substitution on the cytotoxic potential of pyrazole tethered chalcones , 2012, Medicinal Chemistry Research.

[3]  W. El-Deiry,et al.  The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo , 2011, Cell cycle.

[4]  M. Doble,et al.  Novel chalcones and 1,3,5‐triphenyl‐2‐pyrazoline derivatives as antibacterial agents , 2010, Chemical biology & drug design.

[5]  H. Harada,et al.  Synthesis and biological evaluation of indolyl chalcones as antitumor agents. , 2010, Bioorganic & medicinal chemistry letters.

[6]  K. Park,et al.  Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. , 2010, European journal of medicinal chemistry.

[7]  H. Tokuda,et al.  Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents , 2010, Journal of Asian natural products research.

[8]  T. Stanojković,et al.  Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety. , 2010, Bioorganic chemistry.

[9]  A. Maguire,et al.  Asymmetric 1,3-dipolar cycloadditions of acrylamides. , 2010, Chemical Society reviews.

[10]  B. N. Sinha,et al.  Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. , 2010, Bioorganic & medicinal chemistry letters.

[11]  Liangpeng Sun,et al.  Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives , 2010, Medicinal Chemistry Research.

[12]  M. Koyama,et al.  Applying ultra-accelerated quantum chemical molecular dynamics technique for the evaluation of ligand protein interactions , 2010, Medicinal Chemistry Research.

[13]  W. Krol,et al.  Chalcones Enhance TRAIL-Induced Apoptosis in Prostate Cancer Cells , 2009, International journal of molecular sciences.

[14]  M. Čolović,et al.  Synthesis, spectral characterization and electrochemical properties of 1H-3-(o-, m-and p-ferrocenylphenyl)-1-phenylpyrazole-4-carboxaldehydes , 2009 .

[15]  R. Palić,et al.  Synthesis and antimicrobial activity of some new pyrazole derivatives containing a ferrocene unit. , 2009, Bioorganic & medicinal chemistry letters.

[16]  J. Santibañez,et al.  Structural Antitumoral Activity Relationships of Synthetic Chalcones , 2009, International journal of molecular sciences.

[17]  Satish K. Awasthi,et al.  Potent antimalarial activity of newly synthesized substituted chalcone analogs in vitro , 2009, Medicinal Chemistry Research.

[18]  M. Degani,et al.  Synthesis and biological evaluation of α, β-unsaturated ketone as potential antifungal agents , 2009, Medicinal Chemistry Research.

[19]  K. Lahtchev,et al.  Antifungal activity of chalcones: a mechanistic study using various yeast strains. , 2008, European journal of medicinal chemistry.

[20]  C. Hung,et al.  Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2',5'-dialkoxylchalcones as cancer chemopreventive agents. , 2008, Bioorganic & medicinal chemistry.

[21]  A. Brancale,et al.  Design, synthesis, and biological evaluation of thiophene analogues of chalcones. , 2008, Bioorganic & medicinal chemistry.

[22]  J. Heilmann,et al.  Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. , 2008, Bioorganic & medicinal chemistry.

[23]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[24]  Hye-Sook Kim,et al.  In vitro Antimalarial Activity of Flavonoids and Chalcones , 2007 .

[25]  Mohamed Ashraf Ali,et al.  Discovery of novel phenoxyacetic acid derivatives as antimycobacterial agents. , 2007, Bioorganic & medicinal chemistry.

[26]  Z. Nowakowska.  A review of anti-infective and anti-inflammatory chalcones. , 2007, European journal of medicinal chemistry.

[27]  K. Lee,et al.  Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents. , 2006, Journal of natural products.

[28]  G. Achanta,et al.  A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the Proteasome , 2006, Molecular Pharmacology.

[29]  J. Snyder,et al.  Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. , 2004, Bioorganic & medicinal chemistry.

[30]  Maria Cristina Burla,et al.  SIR2002: the program , 2003 .

[31]  J. Calixto,et al.  Trypanocidal and Leishmanicidal Properties of Substitution-Containing Chalcones , 2003, Antimicrobial Agents and Chemotherapy.

[32]  Anthony L. Spek,et al.  Journal of , 1993 .

[33]  K. Lee,et al.  Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. , 2002, Bioorganic & medicinal chemistry.

[34]  P. Wilairat,et al.  Antimalarial activity of ferrocenyl chalcones. , 2002, Bioorganic & medicinal chemistry letters.

[35]  Albert Léavai.  Synthesis of 2-pyrazolines by the reactions of α,β-unsaturated aldehydes, ketones, and esters with diazoalkanes, nitrile imines, and hydrazines , 2002 .

[36]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[37]  H. Nishino,et al.  Inhibitory effects of dehydrozingerone and related compounds on 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation. , 1998, Cancer letters.

[38]  M. Alcaraz,et al.  Synthesis and anti-inflammatory activity of chalcone derivatives. , 1998, Bioorganic & medicinal chemistry letters.

[39]  Louis J. Farrugia,et al.  ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .

[40]  A. Galbraith,et al.  Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. , 1994, Cancer letters.

[41]  B. Katzenellenbogen,et al.  Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells. , 1986, Cancer research.

[42]  C. R. Dawson,et al.  Alkenylphenols Related to the Poison Ivy Principle. An Improved Method of Synthesis Involving the Na-Butanol Cleavage of Benzyl Ethers , 1956 .